Astellas Pharma
4503.T
$14.19
Share price
-0.97%
Change (1 day)
-12.78%
Change (1 year)
Categories
Earnings for Astellas Pharma (4503.T)
Earnings in 2022 (TTM): $1.21 B
According to Astellas Pharma's latest financial reports the company's current earnings (TTM) are $1.21 B. In 2021 the company made an earning of $1.30 B a decrease over its 2020 earnings that were of $1.61 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Astellas Pharma from 2009 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $1.21 B | -7.02% |
| 2021 | $1.30 B | -19.12% |
| 2020 | $1.61 B | -36.08% |
| 2019 | $2.53 B | 13.84% |
| 2018 | $2.22 B | 12.35% |
| 2017 | $1.97 B | -23.22% |
| 2016 | $2.57 B | 21.43% |
| 2015 | $2.12 B | 41.78% |
| 2014 | $1.49 B | 24.86% |
| 2013 | $1.19 B | 0.04% |
| 2012 | $1.19 B | -34.9% |
| 2011 | $1.84 B | 32.31% |
| 2010 | $1.39 B | -36.62% |
| 2009 | $2.19 B |